Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance

Evaluation of a complementary metal oxide semiconductor detector as a tool for stereotactic body radiotherapy plan quality assurance

Background and purpose: A sub-mm resolution Complementary Metal Oxide Semiconductor sensor has been developed for stereotactic radiotherapy quality assurance. Herein we evaluate its basic dosimetric performance and its application for linac C-arm stereotactic body radiotherapy (SBRT) plan quality as...

Full description

Bibliographic Details
Main Authors:	Chris J. Stepanek, Jackie A. Haynes, Sally Fletcher
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Physics and Imaging in Radiation Oncology
Subjects:	Stereotactic body radiotherapy Quality assurance Spatial resolution Dosimetric characterisation Clinical dose measurement Delivery error sensitivity
Online Access:	http://www.sciencedirect.com/science/article/pii/S240563162300009X

Similar Items

Stereotactic Radiotherapy for Brain Metastases: Imaging Tools and Dosimetric Predictive Factors for Radionecrosis
by: Marco Lupattelli, et al.
Published: (2020-07-01)

A Combined Model to Improve the Prediction of Local Control for Lung Cancer Patients Undergoing Stereotactic Body Radiotherapy Based on Radiomic Signature Plus Clinical and Dosimetric Parameters
by: Li-Mei Luo, et al.
Published: (2022-01-01)

Stereotactic Radiation Therapy of Single Brain Metastases: A Literature Review of Dosimetric Studies
by: Isabelle Chambrelant, et al.
Published: (2023-08-01)

Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
by: Angèle Dubouloz, et al.
Published: (2018-06-01)

Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer
by: Christoph A. Fink, et al.
Published: (2024-02-01)

A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma
by: Sergiu Scobioala, et al.
Published: (2019-08-01)

Stereotactic Radiosurgery/Radiotherapy: A Historical Review
by: Mansoureh Nabavi, et al.
Published: (2014-04-01)

Dummy run quality assurance study in the Korean Radiation Oncology Group 19 − 09 multi-institutional prospective cohort study of breast cancer
by: Myeongsoo Kim, et al.
Published: (2022-11-01)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
by: N V. N. Madhusudhana Sresty, et al.
Published: (2021-01-01)

Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases
by: Leonie Johannwerner, et al.
Published: (2023-04-01)

Optimal planning strategy among various arc arrangements for prostate stereotactic body radiotherapy with volumetric modulated arc therapy technique
by: Kang Sang Won, et al.
Published: (2017-01-01)

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy
by: Harish N. Vasudevan, et al.
Published: (2017-06-01)

Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer
by: Yang-Gun Suh, et al.
Published: (2022-07-01)

A framework for exactrac dynamic commissioning for stereotactic radiosurgery and stereotactic ablative radiotherapy
by: Ben Perrett, et al.
Published: (2022-01-01)

Stereotactic Radiosurgery and Stereotactic Fractionated Radiotherapy in the Management of Brain Metastases
by: Sofian Benkhaled, et al.
Published: (2024-03-01)

A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer
by: Takuro Kainuma, et al.
Published: (2019-09-01)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
by: Bin Qiu, et al.
Published: (2020-08-01)

Robotic Stereotactic Radiotherapy for Intracranial Meningiomas—An Opportunity for Radiation Dose De-Escalation
by: Hanna Grzbiela, et al.
Published: (2023-11-01)

Dose-effect relationship of linear accelerator based stereotactic radiotherapy for brain metastases
by: Ning Wu, et al.
Published: (2023-10-01)

Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
by: Kevin T. Tran, et al.
Published: (2023-03-01)

Dose-Response Effect and Dose-Toxicity in Stereotactic Radiotherapy for Brain Metastases: A Review
by: Maxime Loo, et al.
Published: (2021-12-01)

Developments in Stereotactic Body Radiotherapy
by: Anoop Haridass
Published: (2018-12-01)

Stereotactic ablative radiotherapy for primary renal cell carcinoma
by: Daniel X. Yang, et al.
Published: (2024-01-01)

Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control
by: Naoyuki Kanayama, et al.
Published: (2022-12-01)

Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy
by: Laura Burgess, et al.
Published: (2020-10-01)

The Impact of Clinical Trial Quality Assurance on Outcome in Head and Neck Radiotherapy Treatment
by: Haoyu Zhong, et al.
Published: (2019-08-01)

Stereotactic radiotherapy: An educational narrative review
by: Agha Muhammad Hammad Khan, et al.
Published: (2024-03-01)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01)

Stereotactic Radiotherapy in Uveal Melanoma
by: Ela Delikgöz Soykut, et al.
Published: (2014-09-01)

Stereotactic Radiotherapy for Oligometastasis
by: Sotaro Otake, et al.
Published: (2019-01-01)

Evaluation and performance of arccheck and film using gamma criteria in pre-treatment quality assurance of stereotactic ablative radiotherapy
by: Prabhakar Ramachandran, et al.
Published: (2017-01-01)

Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
by: Jongmoo Park, et al.
Published: (2019-09-01)

Clinical outcomes and toxicity using Stereotactic Body Radiotherapy (SBRT) for advanced cholangiocarcinoma
by: Barney Brandon M, et al.
Published: (2012-05-01)

Stereotactic Radiotherapy and Particle Therapy for Pancreatic Cancer
by: Sweet Ping Ng, et al.
Published: (2018-03-01)

Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
by: Robert Olson, et al.
Published: (2018-10-01)

Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions
by: Raphael Jumeau, et al.
Published: (2020-06-01)

Neoadjuvant Stereotactic Radiotherapy for Brain Metastases: Systematic Review and Meta-Analysis of the Literature and Ongoing Clinical Trials
by: Paolo Palmisciano, et al.
Published: (2022-09-01)

The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2020-12-01)

HyperArc VMAT planning for single and multiple brain metastases stereotactic radiosurgery: a new treatment planning approach
by: Shingo Ohira, et al.
Published: (2018-01-01)

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer
by: Katrina Woodford, et al.
Published: (2017-10-01)